scholarly journals PCN90 ASSESSMENT OF UTILITIES FOR ADVERSE EVENTS (AES) ASSOCIATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY IN LARGE B-CELL LYMPHOMA (LBCL)

2020 ◽  
Vol 23 ◽  
pp. S39
Author(s):  
T. Howell ◽  
L. Matza ◽  
M.P. Jun ◽  
J. Garcia ◽  
A. Powers ◽  
...  
Keyword(s):  
Adverse Events ◽  
Cell Therapy ◽  
Chimeric Antigen Receptor ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Large B Cell Lymphoma ◽  
Car T Cell Therapy ◽  
Car T ◽  
Large B Cell

Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma

2021 ◽  
Vol 2021 (9) ◽  
Author(s):  
Moritz Ernst ◽  
Annika Oeser ◽  
Burcu Besiroglu ◽  
Julia Caro-Valenzuela ◽  
Mohamed Abd El Aziz ◽  
...  
Keyword(s):  
Cell Therapy ◽  
B Cell ◽  
Chimeric Antigen Receptor ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Large B Cell Lymphoma ◽  
Car T Cell Therapy ◽  
Car T ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document